StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Ascendis Pharma A/S
NasdaqGS:ASND
Sector
Location
Market Cap
USD 10.68 B
Share Price
USD 174.96
Avg Daily Volume
488,423
Change (1 day)
-0.87%
Change (1 year)
28.92%
Change (YTD)
27.09%
Ascendis Pharma A/S Operating Cash Flow for the Trailing 12 Months (TTM) ending December 31, 2024: USD -328.29 M
Ascendis Pharma A/S Operating Cash Flow is USD -328.29 M for the Trailing 12 Months (TTM) ending December 31, 2024, a -35.02% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Ascendis Pharma A/S Operating Cash Flow for the Trailing 12 Months (TTM) ending December 31, 2023 was USD -505.24 M, a -3.51% change year over year.
-
Ascendis Pharma A/S Operating Cash Flow for the Trailing 12 Months (TTM) ending December 31, 2022 was USD -523.60 M, a 7.83% change year over year.
-
Ascendis Pharma A/S Operating Cash Flow for the Trailing 12 Months (TTM) ending December 31, 2021 was USD -485.57 M, a 53.98% change year over year.
-
Ascendis Pharma A/S Operating Cash Flow for the Trailing 12 Months (TTM) ending December 31, 2020 was USD -315.36 M, a 61.27% change year over year.
Competitors
GE HealthCare Technologies Inc.
USD 75.13
GEHC
-1.37
-1.79%
Laboratory Corporation of America Holdings
USD 249.62
LH
-4.01
-1.58%
Torrent Pharmaceuticals Limited
USD 38.57
TORNTPHARM.NS
-0.37
-0.96%
Regencell Bioscience Holdings Limited
USD 14.75
RGC
-1.82
-10.98%
Laurus Labs Limited
USD 9.20
LAURUSLABS.NS
-0.06
-0.62%
ADMA Biologics, Inc.
USD 18.51
ADMA
+0.04
0.22%
Ipca Laboratories Limited
USD 16.87
IPCALAB.NS
+0.03
0.15%
Shijiazhuang Yiling Pharmaceutical Co., Ltd.
USD 2.08
002603.SZ
+0.00
0.15%
Hubei Jumpcan Pharmaceutical Co., Ltd.
USD 3.66
600566.SS
+0.00
0.00%
Pfizer Limited
USD 64.20
PFIZER.NS
+0.37
0.58%
BGI Genomics Co., Ltd.
USD 6.92
300676.SZ
+0.06
0.93%
Eris Lifesciences Limited
USD 19.90
ERIS.NS
-0.44
-2.16%
Liaoning Cheng Da Co., Ltd.
USD 1.63
600739.SS
+0.03
1.74%
Vimian Group AB (publ)
USD 4.35
VIMIAN.ST
-0.14
-3.04%
Hybio Pharmaceutical Co., Ltd.
USD 2.58
300199.SZ
+0.04
1.56%
NovoCure Limited
USD 17.60
NVCR
-0.86
-4.66%
Harmony Biosciences Holdings, Inc.
USD 34.00
HRMY
-0.33
-0.96%
Zhejiang Jingxin Pharmaceutical Co., Ltd.
USD 2.17
002020.SZ
+0.03
1.32%
Adaptive Biotechnologies Corporation
USD 11.82
ADPT
-0.26
-2.15%
Arcutis Biotherapeutics, Inc.
USD 15.01
ARQT
-0.26
-1.70%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
GE HealthCare Technologies Inc.
USD 75.13
GEHC
-1.37
-1.79%
Laboratory Corporation of America Holdings
USD 249.62
LH
-4.01
-1.58%
Torrent Pharmaceuticals Limited
USD 38.57
TORNTPHARM.NS
-0.37
-0.96%
Regencell Bioscience Holdings Limited
USD 14.75
RGC
-1.82
-10.98%
Laurus Labs Limited
USD 9.20
LAURUSLABS.NS
-0.06
-0.62%
ADMA Biologics, Inc.
USD 18.51
ADMA
+0.04
0.22%
Ipca Laboratories Limited
USD 16.87
IPCALAB.NS
+0.03
0.15%
Shijiazhuang Yiling Pharmaceutical Co., Ltd.
USD 2.08
002603.SZ
+0.00
0.15%
Hubei Jumpcan Pharmaceutical Co., Ltd.
USD 3.66
600566.SS
+0.00
0.00%
Pfizer Limited
USD 64.20
PFIZER.NS
+0.37
0.58%
BGI Genomics Co., Ltd.
USD 6.92
300676.SZ
+0.06
0.93%
Eris Lifesciences Limited
USD 19.90
ERIS.NS
-0.44
-2.16%
Liaoning Cheng Da Co., Ltd.
USD 1.63
600739.SS
+0.03
1.74%
Vimian Group AB (publ)
USD 4.35
VIMIAN.ST
-0.14
-3.04%
Hybio Pharmaceutical Co., Ltd.
USD 2.58
300199.SZ
+0.04
1.56%
NovoCure Limited
USD 17.60
NVCR
-0.86
-4.66%
Harmony Biosciences Holdings, Inc.
USD 34.00
HRMY
-0.33
-0.96%
Zhejiang Jingxin Pharmaceutical Co., Ltd.
USD 2.17
002020.SZ
+0.03
1.32%
Adaptive Biotechnologies Corporation
USD 11.82
ADPT
-0.26
-2.15%
Arcutis Biotherapeutics, Inc.
USD 15.01
ARQT
-0.26
-1.70%